An a priori generalizability metric GIST 2.0 for individual trials is proposed.
GIST 2.0 indicates relative restrictiveness of clinical eligibility criteria.
The dependencies and significance of traits are explicitly modeled.
GIST 2.0 is evaluated on twenty trials and the scores are statistically analyzed.
GIST 2.0 is validated with set-theoretic analysis and simulations.